title: [Defining remission in Rheumatoid Arthritis. New ACR/EULAR criteria].
abstract: Remission is the ideal treatment objective in the management of rheumatoid arthritis. To define remission, stringent criteria are needed which allow clinicians to assess the presence of active disease and which should be reliable enough to support therapeutic decisions. Currently there are many different remission classifications and none has been validated against important outcome measures such as the absence of progression of joint damage and disability. Recently, a subcommittee of the ACR and EULAR has proposed new criteria for remission based on a categorical classification and a composite score like SDAI allowing their use in clinical practice.
authors.affiliation: Servicio de Reumatología, Hospital Universitario La Paz, Reumatología, Universidad Autónoma de Madrid, Madrid, España. abalsa.hulp@salud.madrid.org
authors.forename: Alejandro
authors.initials: A
authors.lastname: Balsa
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005060:Europe; D006801:Humans; D012074:Remission Induction; D012219:Rheumatology / Q000592:standards; D012955:Societies, Medical / Q000592:standards; D063189:Symptom Assessment; D016896:Treatment Outcome; D014481:United States
chemical_list: D018501:Antirheumatic Agents